Mid-Atlantic Section of the American Urological Association (MAAUA) Search MA-AUA
Mid-Atlantic Section of the American Urological Association (MAAUA)
Home | About Us | Contact Us   
  Home
  Members
    Members Only Area
    Member Directory
    Join the MA-AUA
  Annual Meeting
  Future Meetings
  Board of Directors
  Committees
  Careers
  Newsletters
  Visit the AUA
  Advocacy Efforts

 
  Members Only
  Username
 
  Password
 
   Forgot Password?

 
 

67th Annual Meeting Abstracts


Overactive Bladder Medication Adherence When Medications Are Free To The Patients
Christine L Gray Sears1, *Christa Lewis2, *Kathleen Noel3, *Todd S Albright4, *John R Fischer4
1Department of Urology, National Naval Medical Center, Bethesda, MD;2National Capitol Consortium Uniformed Services Residency in Obstetrics and Gynecology, Bethesda, MD;3Female Pelvic Medicine and Reconstructive Surgery, Walter Reed Army Medical Center, Washington, DC;4Female Pelvic Medicine and Reconstructive Surgery, Walter Reed Army Medical Center, Washington, DC

Introduction: In order to examine the effect of medication cost on medication compliance, we examined overactive bladder medication compliance in a healthcare system where patients do not pay for their medications.
Materials & Methods:
Pharmacy dispensing records were reviewed for antimuscarinic agents from January 2003 to December 2006 for the National Capital Region of the U.S. Military Health System. Medication non-persistence, switching, and adherence were examined. Kaplan Meier survival analysis was performed to compare medication persistence duration.
Results:
Overactive bladder medications were dispensed to 7,879 adults. Tolterodine extended release (4,716 prescriptions) and oxybutynin immediate release (2,003 prescriptions) were most commonly prescribed. The medication non-persistence rate was 35.1% (2,760/7,858). Of 5,098 subjects who refilled their prescriptions, 1,305 changed their medication or dosage at least once, for a medication switch rate of 25.6%. The overall median Medication Possession Ratio (MPR) was 0.82 for all subjects. Men had a significantly higher median MPR than women (0.86 vs. 0.81, p<0.001). However, among patients who obtained at least one refill, women stayed on medications longer than men (Median 606 days vs. 547 days, p=0.01). Patients on tolterodine extended release had a higher MPR than those on oxybutynin immediate release (0.89 vs. 0.68, p<0.01). There was no difference between any different extended release medications.
Conclusions:
In a health care system in which patients do not pay for medications, 35% of patients do not refill their prescription for overactive bladder medications. Other measures of medication compliance are higher than those published previously in systems with co-pays.


 

 

 
     
     
Copyright © 2010 Mid-Atlantic Section of the American Urological Association. All Rights Reserved.
Read Privacy Policy.